Skip to content

Early Detection of Novel Coronavirus Pneumonia (COVID-19) Based on a Novel High-Throughput Mass Spectrometry Analysis With Exhaled Breath

Early Detection of Novel Coronavirus Pneumonia (COVID-19) Based on a Novel High-Throughput Mass Spectrometry Analysis With Volatile Organic Compounds in Exhaled Breath

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2000029695
Enrollment
Unknown
Registered
2020-02-10
Start date
2020-03-01
Completion date
Unknown
Last updated
2021-08-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

novel coronavirus pneumonia (COVID-19)

Interventions

Gold Standard:RT-PCR of the novel coronavirus
detection&#32
by&#32

Sponsors

Shenzhen Third People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Years to 100 Years

Inclusion criteria

Inclusion criteria: Suspected cases of pneumonitis with the novel coronavirus infection. Suspected case criteria: Any one of the following epidemiological histories meets any two of the clinical manifestations: Comprehensive analysis based on the following epidemiological history and clinical manifestations: 1. Epidemiological history: (1) Travel history or residence history of Wuhan and surrounding areas or other communities with case reports within 14 days before the onset of illness; (2) Onset of illness Patients with fever or respiratory symptoms from Wuhan and surrounding areas, or from communities with case reports in the previous 14 days; (3) Aggressive onset; (4) History of contact with new coronavirus infection. People with a new coronavirus infection are those who test positive for nucleic acid. 2. Clinical manifestations (1) fever and/or respiratory symptoms; (2) with the imaging mentioned above characteristics of pneumonia; (3) the total number of white blood cells is normal or decreased in the early stage of onset, or the lymphocyte count is decreased.

Exclusion criteria

Exclusion criteria: Severe novel coronavirus pneumonia patients who cannot provide exhaled breath samples.

Design outcomes

Primary

MeasureTime frame
Sensitivity of detection of NCP;Specificity of detection of NCP;

Countries

China

Contacts

Public ContactDeng Guofang

Shenzhen Third People's Hospital

jxxk1035@yeah.net+86 13530027001

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026